# Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement

Study · id `cardio:ct-nct02673697` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02673697](<https://clinicaltrials.gov/study/NCT02673697>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02673697

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 914 participants.

## Technical summary

Registry record NCT02673697. Randomized; no masking; primary purpose treatment. Start 2016-03-22 (actual); primary completion 2020-01-17 (actual). Results posted on 2022-07-27.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 914 participants (enrolled count; ClinicalTrials.gov record NCT02673697, source copy `cardio:ctgov-nct02673697-2024-03-06`, retrieved 2026-10-26)
- Started: 2016-03-22 (actual) (ClinicalTrials.gov record NCT02673697, source copy `cardio:ctgov-nct02673697-2024-03-06`, retrieved 2026-10-26)
- Primary completion: 2020-01-17 (actual) (ClinicalTrials.gov record NCT02673697, source copy `cardio:ctgov-nct02673697-2024-03-06`, retrieved 2026-10-26)
- Completion: 2020-07-31 (actual) (ClinicalTrials.gov record NCT02673697, source copy `cardio:ctgov-nct02673697-2024-03-06`, retrieved 2026-10-26)
- Results first posted: 2022-07-27 (ClinicalTrials.gov record NCT02673697, source copy `cardio:ctgov-nct02673697-2024-03-06`, retrieved 2026-10-26)
- Countries: United States; Austria; Belgium; Canada; Chile; France; Germany; Israel; Italy; Netherlands; Spain; United Kingdom (ClinicalTrials.gov record NCT02673697, source copy `cardio:ctgov-nct02673697-2024-03-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02673697-2024-03-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement
- Acronym: PERSIST-AVR
- Condition: Aortic Valve Disease
- Condition: Aortic Stenosis
- Intervention (Device): Perceval valve
- Intervention (Device): other stented biological valve
- Lead sponsor: Corcym S.r.l
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Sutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis (`cardio:pubmed-33478837`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Perioperative platelet reduction after sutureless or stented valve implantation: results from the PERSIST-AVR controlled randomized trial (`cardio:pubmed-34118150`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Pacemaker implantation after sutureless or stented valve: results from a controlled randomized trial (`cardio:pubmed-35290444`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c3ba89ec58c89080d7195983cc61cc7fb0fbc5c8b2285cbacc773d07535b3b24
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
